Open Access

Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3‑dimensional culture of colorectal cancer cells

  • Authors:
    • Dahee Kim
    • Byumseok Koh
    • Kwang Rok Kim
    • Ki Young Kim
    • Won Hoon Jung
    • Hi Youn Kim
    • Sungsub Kim
    • Sang Dal Rhee
  • View Affiliations

  • Published online on: September 5, 2019     https://doi.org/10.3892/ol.2019.10813
  • Pages: 4858-4864
  • Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

XAV939, a tankyrase inhibitor, exerts an anticancer effect in 3‑dimensional (3D) cultured SW480 cells, however this is not exhibited in 2‑dimensional (2D) cultured SW480 cells. In the current study, XAV939 induced a 3.7‑fold increase in cellular apoptosis in 3D culture but not in the 2D culture. However, no significant changes were indicated in cell cycle distribution in the 2D or 3D culture. Based on the observation that protein expression, which was associated with the glycolytic pathway, was increased in the 3D culture, the effect of XAV939 on the patterns of glycolytic protein expression was assessed. XAV939 was revealed to decrease lactose dehydrogenase A (LDHA) expression in 3D cultured SW480 cells, but only exerted a small effect in the 2D culture. The coadministration of XAV939 with the LDHA inhibitor FX11 decreased proliferation in 3D cultured SW480 cells compared with the single administration of FX11, while there was no additive effect in the 2D culture. The lactate assay also indicated that XAV939 decreased lactate secretion in the 3D cell culture but not in the 2D culture. These results suggest that XAV939 exerts an anticancer effect through inhibition of LDHA in the 3D culture.
View Figures
View References

Related Articles

Journal Cover

November-2019
Volume 18 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kim D, Koh B, Kim KR, Kim KY, Jung WH, Kim HY, Kim S and Rhee SD: Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3‑dimensional culture of colorectal cancer cells. Oncol Lett 18: 4858-4864, 2019
APA
Kim, D., Koh, B., Kim, K.R., Kim, K.Y., Jung, W.H., Kim, H.Y. ... Rhee, S.D. (2019). Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3‑dimensional culture of colorectal cancer cells. Oncology Letters, 18, 4858-4864. https://doi.org/10.3892/ol.2019.10813
MLA
Kim, D., Koh, B., Kim, K. R., Kim, K. Y., Jung, W. H., Kim, H. Y., Kim, S., Rhee, S. D."Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3‑dimensional culture of colorectal cancer cells". Oncology Letters 18.5 (2019): 4858-4864.
Chicago
Kim, D., Koh, B., Kim, K. R., Kim, K. Y., Jung, W. H., Kim, H. Y., Kim, S., Rhee, S. D."Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3‑dimensional culture of colorectal cancer cells". Oncology Letters 18, no. 5 (2019): 4858-4864. https://doi.org/10.3892/ol.2019.10813